Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Lilly to discontinue or alter rHb1.1 collaboration with Somatogen

March 21, 1997

FDA clears Skelid

March 21, 1997

Amylin and J&J broaden collaboration

March 20, 1997

Collaboration formed to identify chronic anemia treatment

March 20, 1997

Phase II trial of Leukine as adjuvant for advanced melanoma

March 20, 1997

Grelan characterizes candidate for diabetic complications

March 20, 1997

Novel antihyperlipidemic agent from Shionogi in phase II

March 20, 1997

Wyeth-Ayerst acquires commercialization rights to rhIL-11

March 19, 1997

Cabergoline launched in U.S.

March 19, 1997

Preliminary clinical results with CI-1000

March 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...